CAS: 84956-71-8; 2-(Tert-Butyl)-4,5-Dichloropyridazin-3(2H)-One

该化合物是一个化学化合物,其独特结构包括一个含有两个氯替代物和三丁基化合物的丙烯津环,具有两种氯基和三丁基化合物组;该化合物通常具有三环化合物的常见特性,例如有机溶剂中中溶性,以及由于存在卤素原子而具有的潜在反应性;二氯代成分可影响其化学行为,使其成为各种化学反应的候选体,包括肺病替代物;三丁基基元素组会助长阻塞,从而影响该化合物的再活动以及与其他分子的相互作用;此外,碳基元素组在pyridazinone结构中的存在可能会产生酸性特征,从而有可能在医药化学领域或作为有机合成的建筑块进行潜在应用;

结构式图片

相似化合物

933-76-6 33098-10-1 96490-18-5

欧盟法规

C&L通报

上下游产品

CAS号766-40-5 3,4-二氯-5-羟基-5H-... | CAS号7400-27-3 叔丁基肼盐酸盐 | CAS号330196-02-6 4-Amino-2-(tert... | CAS号863887-89-2 Flurpiridaz F-18 | CAS号88093-48-5 4-氯-2-(1,1-二甲基乙... | CAS号96490-18-5 4-氯-2-(1,1-二甲基乙...

合成工艺路线路线简述

  • 7400-27-3 + 57697-64-0 = 84956-71-8
    反应条件:1.1 Reagents: Sodium Carbonate Solvents: Water; 2.5 H,Cooled1.2 Solvents: Acetic Acid,Benzene; 4 H,35 - 45 °C
    标题:Preparation And Biodistribution Of [18F]Fp2Op As Myocardial Perfusion Imaging Agent For Positron Emission Tomography
    作者:Mou,Tiantian; Jing,Huihui; Yang,Wenjiang; Fang,Wei; Peng,Cheng; Et Al
    参考文献:Bioorganic & Medicinal Chemistry 日期:2010 卷标:18(3) 页码:1312-1320]

    7400-27-3 = 84956-71-8
    反应条件:1.1 Reagents: Acetic Acid,Sodium Hydroxide Solvents: Toluene,Water
    标题:Preparation Of 3(2H)-Pyridazinones As Intermediates For Insecticides
    参考文献:Japan]

    32064-67-8 = 84956-71-8
    反应条件:1.1 Reagents: Acetic Acid Solvents: Toluene,Water; 30 Min,Rt; 4 H,46 - 48 °C1.2 Reagents: Sodium Hydroxide Solvents: Water
    标题:Synthesis Of Pyridaben Active Compound With High Content
    作者:Wu,Xing-Ye; Wang,Chong-Lei
    参考文献:Huaxue Yu Nianhe 日期:2014 卷标:36(6) 页码:430-432]

    7400-27-3 + 57697-64-0 = 84956-71-8
    反应条件:1.1 Reagents: Sodium Acetate Solvents: Toluene,Water; 10 °C; 1 H,10 °C; 6 H,40 °C
    标题:Synthesis And Antitumor Activity Of Novel Pyridazinone Derivatives Containing 1,3,4-Thiadiazole Moiety
    作者:Qin,Junhu; Zhu,Mei; Zhu,Hongmei; Zhang,Liqiong; Fu,Yihong; Et Al
    参考文献:Phosphorus 日期:2020 卷标:195(7) 页码:592-599]

    7400-27-3 = 84956-71-8
    反应条件:1.1 Reagents: Sodium Carbonate Solvents: Water; 15 Min,0 °C1.2 2.5 H,0 °C1.3 Reagents: Acetic Acid; 1 H,Reflux
    标题:Automated Synthesis Of 18F-Bcpp-Ef {2-Tert-Butyl-4-Chloro-5-{6-[2-(2[18F] Fluoroethoxy)-Ethoxy]-Pyridin- 3-Ylmethoxy}-2H-Pyridazin-3-One For Imaging Of Mitochondrial Complex 1 In Parkinson'S Disease
    作者:Kaur,Tanpreet; Brooks,Allen F.; Liddell,Katherine M.; Henderson,Bradford D.; Hockley,Brian G.; Et Al
    参考文献:Frontiers In Chemistry (Lausanne 日期:2022 卷标:10
📜叔丁基肼盐酸盐 以 甲醇 作为反应溶剂,化学反应生成 哒嗪酮
参考文献:Prostaglandin Endoperoxide H Synthase Biosynthesis Inhibitors
标题:Prostaglandin Endoperoxide H Synthase Biosynthesis Inhibitors
摘要:该发明描述了式i的吡啶并酮化合物,这些化合物是环氧合酶(cox)抑制剂,特别是选择性地抑制环氧合酶-2(cox-2).cox-2是与炎症相关的可诱导异构体,与构成性异构体环氧合酶-1(cox-1)相对,后者是许多组织中重要的"基础"酶,包括胃肠道(gi)和肾脏.这些化合物对cox-2的选择性减少了目前市售的非甾体类抗炎药(nsaids)所见到的不良胃肠道和肾脏副作用.

专利信息


专利号:US-9603951-B2
优先权日:2010-02-08
标题 :Methods and apparatus for synthesizing imaging agents, and intermediates thereof
发明人:LAZEWATSKY JOEL; DEVINE MARYBETH
权利人:LANTHEUS MEDICAL IMAGING INC
摘要:The present invention generally relates to methods and system for the synthesis of imaging agents, and precursors thereof. The methods may exhibit improved yields and may allow for the large-scale synthesis of imaging agents, including imaging agents comprising a radioisotope (e.g., 18 F). Various embodiments of the invention may be useful as sensors, diagnostic tools, and the like. In some cases, methods for evaluating perfusion, including myocardial perfusion, are provided. Synthetic methods of the invention have also been incorporated into an automated synthesis unit to prepare and purify imaging agents that comprise a radioisotope. In some embodiments, the present invention provides a novel methods and systems comprising imaging agent 1, including methods of imaging in a subject comprising administering a composition comprising imaging agent 1 to a subject by injection, infusion, or any other known method, and imaging the area of the subject wherein the event of interest is located.

专利号:US-9919064-B2
优先权日:2012-08-10
标 题 :Compositions, methods, and systems for the synthesis and use of imaging agents
发明人:CESATI RICHARD R; RADEKE HEIKE S; PANDEY SURESH K; PUROHIT AJAY; ROBINSON SIMON P
权利人:LANTHEUS MEDICAL IMAGING INC
摘要:The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, a composition or plurality of imaging agents is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

专利号:US-2018318456-A1
优先权日:2012-08-10
标题:Compositions, methods, and systems for the synthesis and use of imaging agents

专利号:US-2020230264-A1
优先权日:2012-08-10
标 题 :Compositions, methods, and systems for the synthesis and use of imaging agents

专利号:WO-2014026079-A2
优先权日:2012-08-10
标题 :Compositions, methods, and systems of the synthesis and use of imaging agents

专利号:CN-104718193-A
优先权日:2012-08-10
标题 :Compositions, methods, and systems for synthesis and use of contrast agents

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1002/pro.70365
摘要:Katinas JM, Amporndanai K, Taylor AJ, Rose KL, Gareiss PC, Crespo RA, Phan J, Waterson AG, Fesik SW. Nuclear Magnetic Resonance ‐based fragment screen of the E3 ligase Fem‐1 homolog B. Protein Science. 2025 Nov 13;34(12). doi: 10.1002/pro.70365.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知